62 related articles for article (PubMed ID: 38475819)
21. PET Imaging for Gynecologic Malignancies.
Friedman SN; Itani M; Dehdashti F
Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
[TBL] [Abstract][Full Text] [Related]
22. The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions.
Delgado Bolton RC; Calapaquí Terán AK; Pellet O; Ferrero A; Giammarile F
Clin Nucl Med; 2021 Nov; 46(11):906-907. PubMed ID: 34238809
[No Abstract] [Full Text] [Related]
23. Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction.
Lin CN; Huang WS; Huang TH; Chen CY; Huang CY; Wang TY; Liao YS; Lee LW
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33917997
[TBL] [Abstract][Full Text] [Related]
24. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
25. Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma.
Veeraraghavan H; Vargas HA; Jimenez-Sanchez A; Micco M; Mema E; Lakhman Y; Crispin-Ortuzar M; Huang EP; Levine DA; Grisham RN; Abu-Rustum N; Deasy JO; Snyder A; Miller ML; Brenton JD; Sala E
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33212885
[No Abstract] [Full Text] [Related]
26. Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.
Wall JA; Meza-Perez S; Scalise CB; Katre A; Londoño AI; Turbitt WJ; Randall T; Norian LA; Arend RC
Gynecol Oncol; 2021 Jan; 160(1):285-294. PubMed ID: 33168307
[TBL] [Abstract][Full Text] [Related]
27. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets.
Nameki R; Chang H; Reddy J; Corona RI; Lawrenson K
Pharmacol Ther; 2021 Apr; 220():107722. PubMed ID: 33137377
[TBL] [Abstract][Full Text] [Related]
28. Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer.
Himoto Y; Veeraraghavan H; Zheng J; Zamarin D; Snyder A; Capanu M; Nougaret S; Vargas HA; Shitano F; Callahan M; Wang W; Sala E; Lakhman Y
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914033
[TBL] [Abstract][Full Text] [Related]
29. Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian Cancer.
Lakis S; Kotoula V; Koliou GA; Efstratiou I; Chrisafi S; Papanikolaou A; Zebekakis P; Fountzilas G
Cancer Genomics Proteomics; 2020; 17(5):529-541. PubMed ID: 32859631
[TBL] [Abstract][Full Text] [Related]
30. Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer.
Fabbro M; Colombo PE; Leaha CM; Rouanet P; Carrère S; Quenet F; Gutowski M; Mourregot A; D'Hondt V; Coupier I; Vendrell J; Vilquin P; Pujol P; Solassol J; Mollevi C
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764409
[No Abstract] [Full Text] [Related]
31. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer.
Stålberg K; Jónsdóttir B
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):763-764. PubMed ID: 32468349
[No Abstract] [Full Text] [Related]
33. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
Beer L; Sahin H; Bateman NW; Blazic I; Vargas HA; Veeraraghavan H; Kirby J; Fevrier-Sullivan B; Freymann JB; Jaffe CC; Brenton J; Miccó M; Nougaret S; Darcy KM; Maxwell GL; Conrads TP; Huang E; Sala E
Eur Radiol; 2020 Aug; 30(8):4306-4316. PubMed ID: 32253542
[TBL] [Abstract][Full Text] [Related]
34. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Zwanenburg A; Vallières M; Abdalah MA; Aerts HJWL; Andrearczyk V; Apte A; Ashrafinia S; Bakas S; Beukinga RJ; Boellaard R; Bogowicz M; Boldrini L; Buvat I; Cook GJR; Davatzikos C; Depeursinge A; Desseroit MC; Dinapoli N; Dinh CV; Echegaray S; El Naqa I; Fedorov AY; Gatta R; Gillies RJ; Goh V; Götz M; Guckenberger M; Ha SM; Hatt M; Isensee F; Lambin P; Leger S; Leijenaar RTH; Lenkowicz J; Lippert F; Losnegård A; Maier-Hein KH; Morin O; Müller H; Napel S; Nioche C; Orlhac F; Pati S; Pfaehler EAG; Rahmim A; Rao AUK; Scherer J; Siddique MM; Sijtsema NM; Socarras Fernandez J; Spezi E; Steenbakkers RJHM; Tanadini-Lang S; Thorwarth D; Troost EGC; Upadhaya T; Valentini V; van Dijk LV; van Griethuysen J; van Velden FHP; Whybra P; Richter C; Löck S
Radiology; 2020 May; 295(2):328-338. PubMed ID: 32154773
[TBL] [Abstract][Full Text] [Related]
35. AI-based computer-aided diagnosis (AI-CAD): the latest review to read first.
Fujita H
Radiol Phys Technol; 2020 Mar; 13(1):6-19. PubMed ID: 31898014
[TBL] [Abstract][Full Text] [Related]
36. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
Singh N; Piskorz AM; Bosse T; Jimenez-Linan M; Rous B; Brenton JD; Gilks CB; Köbel M
J Pathol; 2020 Mar; 250(3):336-345. PubMed ID: 31829441
[TBL] [Abstract][Full Text] [Related]
37. PET/CT for Evaluation of Ovarian Cancer.
Kemppainen J; Hynninen J; Virtanen J; Seppänen M
Semin Nucl Med; 2019 Nov; 49(6):484-492. PubMed ID: 31630732
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.
Paschalis A; Sheehan B; Riisnaes R; Rodrigues DN; Gurel B; Bertan C; Ferreira A; Lambros MBK; Seed G; Yuan W; Dolling D; Welti JC; Neeb A; Sumanasuriya S; Rescigno P; Bianchini D; Tunariu N; Carreira S; Sharp A; Oyen W; de Bono JS
Eur Urol; 2019 Oct; 76(4):469-478. PubMed ID: 31345636
[TBL] [Abstract][Full Text] [Related]
39. The impact of infection and inflammation in oncologic
Rahman WT; Wale DJ; Viglianti BL; Townsend DM; Manganaro MS; Gross MD; Wong KK; Rubello D
Biomed Pharmacother; 2019 Sep; 117():109168. PubMed ID: 31334700
[TBL] [Abstract][Full Text] [Related]
40. Radiomics: an Introductory Guide to What It May Foretell.
Nougaret S; Tibermacine H; Tardieu M; Sala E
Curr Oncol Rep; 2019 Jun; 21(8):70. PubMed ID: 31240403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
